Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1026651000241117 | médicament contenant aducanumab, forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 1026661000241119 | médicament contenant aducanumab, forme parentérale (forme du produit médicinal) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 4590369015 | Aducanumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4590370019 | Product containing aducanumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| médicament contenant aducanumab, forme parentérale | est un(e) (attribut) | médicament contenant aducanumab | true | Inferred relationship | Some | ||
| médicament contenant aducanumab, forme parentérale | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| médicament contenant aducanumab, forme parentérale | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| médicament contenant aducanumab, forme parentérale | a pour principe actif (attribut) | Aducanumab (substance) | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aducanumab only product in parenteral dose form | est un(e) (attribut) | True | médicament contenant aducanumab, forme parentérale | Inferred relationship | Some |
This concept is not in any reference sets
FHIR